image
Moleculin Biotech, Inc. MBRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.71
-12.3 %
$ 8.14 M
Market Cap
-0.23
P/E
BALANCE SHEET
38.2 M ASSETS
-33.45%
Growth Rates
1Year -33.45%
3Years 9.60%
5Years 14.31%
7Years 12.85%
10Years 0.00%
12.1 M LIABILITIES
132.15%
Growth Rates
1Year 132.15%
3Years 2.52%
5Years 17.98%
7Years 35.71%
10Years 0.00%
26.1 M EQUITY
-50.04%
Growth Rates
1Year -50.04%
3Years 13.65%
5Years 12.81%
7Years 8.26%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Moleculin Biotech, Inc.
image
Current Assets 26.3 M
Cash & Short-Term Investments 23.6 M
Receivables 99 K
Other Current Assets 2.62 M
Non-Current Assets 11.9 M
Long-Term Investments 0
PP&E 796 K
Other Non-Current Assets 11.1 M
Current Liabilities 6.82 M
Accounts Payable 2.5 M
Short-Term Debt 100 K
Other Current Liabilities 4.22 M
Non-Current Liabilities 5.33 M
Long-Term Debt 474 K
Other Non-Current Liabilities 4.86 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 23.6 43.1 70.9 15.2 10.7 7.1 7.7 5.0 28.1 K
Short Term Investments 0 0 0 0 0 0 0 0 0
Receivables 99 K 22 K 45 K 1 K 11 K 0 0 0 0
Inventory 0 22 K 45 K 1.9 2.2 0 0 0 0
Other Current Assets 2.6 1.6 1.1 2.0 2.7 1.0 0.6 0.2 0
Total Current Assets 26.3 45.6 72.5 17.2 13.5 8.0 8.3 5.2 28.1 K
PP&E 0.8 0.7 0.4 0.7 0.6 0.5 33 K 23.1 K 0
Intangible Assets 11.1 11.1 11.1 11.1 11.1 11.1 11.1 11.1 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0.1 0 0 0 0 3 K
Other Long Term Assets 0 0 0 11.8 K 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 3 K
Total Assets 38.2 57.4 84.1 29.0 25.2 19.6 19.5 16.4 28.1 K
LIABILITIES
Accounts Payable 2.5 2.1 1.4 1.1 2.2 1.2 0.8 0.4 0.2
Short Term Debt 100 K 0.1 96 K 0.1 0.1 0 0 0.3 0.5
Other Current Liabilities 4.2 2.6 2.2 1.7 1.3 2.6 1.4 0.7 87.5 K
Total Current Liabilities 6.8 4.8 3.6 2.9 3.6 3.9 2.2 1.3 0.8
Long Term Debt 0.5 0.3 63 K 0.2 0.3 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 4.9 77 K 1.4 8.2 5.8 1.4 0.1 87.5 K 0
Total Liabilities 12.1 5.2 5.1 11.3 9.7 5.3 2.4 1.4 0.8
EQUITY
Common Stock 33 K 29 K 29 K 69 K 46 K 29 K 21 K 12.2 K 6.66 K
Retained Earnings (131.6) (101.8) (72.8) (56.9) (39.6) (26.4) (14.5) (4.7) (0.7)
Other Accumulative Comprehensive Income/Loss 9 K 12 K 41 K 65 K 31 K 35 K 0 0 3 K
Total Equity 26.1 52.2 79.0 17.8 15.6 14.3 17.1 15.0 (0.7)
Total Liabilities and Equity 38.2 57.4 84.1 29.0 25.2 19.6 19.5 16.4 28.1 K
SHARES OUTSTANDING
Common Shares Outstanding 2.0 1.9 27.7 10.0 7.2 4.3 3.1 1.6 2.4